California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$78.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALT Altimmune, Inc.	$350M	$332,000 0.0% of portfolio	66,422	Q2 2024 Added 4.5%
ARVN Arvinas, Inc.	$394M	$323,000 0.0% of portfolio	46,111	Q2 2024 Added 3.89%
CAPR Capricor Therapeutics, Inc.	$210M	$305,000 0.0% of portfolio	32,237	Q2 2024 Reduced 94.3%
KURA Kura Oncology, Inc.	$393M	$296,000 0.0% of portfolio	44,923	Q2 2024 Added 11.46%
VERV Verve Therapeutics, Inc.	$666M	$290,000 0.0% of portfolio	63,500	Q2 2024 Reduced 8.36%
RLAY Relay Therapeutics, Inc.	$388M	$278,000 0.0% of portfolio	106,287	Q2 2024 Reduced 20.56%
IMNM Immunome Inc.	$106M	$251,000 0.0% of portfolio	37,368	Q2 2024 Added 4.0%
SVRA Savara Inc	$253M	$239,000 0.0% of portfolio	86,465	Q2 2024 Reduced 11.72%
ARCT Arcturus Therapeutics Holdings Inc.	$337M	$239,000 0.0% of portfolio	22,644	Q2 2024 Added 4.29%
CGEM Cullinan Oncology, Inc.	$346M	$236,000 0.0% of portfolio	31,251	Q2 2024 Added 17.3%
ERAS Erasca, Inc.	$170M	$235,000 0.0% of portfolio	171,821	Q2 2024 Reduced 95.24%
MRVI Maravai Lifesciences Holdings, Inc.	$278M	$233,000 0.0% of portfolio	105,622	Q2 2024 Added 3.98%
PHAT Phathom Pharmaceuticals, Inc.	$388M	$221,000 0.0% of portfolio	35,262	Q2 2024 Reduced 17.61%
STOK Stoke Therapeutics, Inc.	$457M	$213,000 0.0% of portfolio	32,068	Q2 2024 Added 3.18%
PHVS Pharvaris N.V.	$588M	$200,000 0.0% of portfolio	12,791	Q1 2025 Reduced 4.73%
SANA Sana Biotechnology, Inc.	$495M	$193,000 0.0% of portfolio	115,034	Q2 2024 Added 12.38%
ORIC Oric Pharmaceuticals, Inc.	$418M	$177,000 0.0% of portfolio	31,833	Q2 2024 Added 10.28%
ATXS Astria Therapeutics, Inc.	$88.9M	$173,000 0.0% of portfolio	32,561	Q2 2024 Reduced 89.98%
TRDA Entrada Therapeutics, Inc.	$221M	$146,000 0.0% of portfolio	16,222	Q2 2024 Added 4.35%
HUMA Humacyte, Inc.	$232M	$139,000 0.0% of portfolio	81,808	Q2 2024 Reduced 92.21%
ANNX Annexon, Inc.	$117M	$128,000 0.0% of portfolio	66,375	Q2 2024 Reduced 90.8%
TYRA Tyra Biosciences, Inc.	$415M	$98,000 0.0% of portfolio	10,570	Q2 2024 Reduced 86.07%
SMMT Summit Therapeutics Inc.	$4.28B	$87,000 0.0% of portfolio	4,540	Q1 2025 Reduced 32.64%
PLRX Pliant Therapeutics, Inc.	$63.8M	$62,000 0.0% of portfolio	46,051	Q2 2024 Reduced 2.45%
XERS Xeris Biopharma Holdings, Inc.	$628M	$55,000 0.0% of portfolio	10,161	Q2 2024 Reduced 24.06%
ENOB Enochian Biosciences Inc	$244M	$39,000 0.0% of portfolio	8,587	Q2 2024 Reduced 58.86%
OMER Omeros Corp	$205M	$33,000 0.0% of portfolio	4,053	Q2 2024 Reduced 33.79%
SAGE Sage Therapeutics, Inc.	$553M	$32,000 0.0% of portfolio	4,034	Q1 2025 Reduced 90.69%
URGN Uro Gen Pharma Ltd.	$310M	$30,000 0.0% of portfolio	2,762	Q1 2025 Reduced 90.19%
AKBA Akebia Therapeutics, Inc.	$675M	$28,000 0.0% of portfolio	15,073	Q2 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$306M	$28,000 0.0% of portfolio	2,511	Q2 2024 Added 9.88%
TRVI Trevi Therapeutics, Inc.	$337M	$28,000 0.0% of portfolio	4,497	Q2 2024 Reduced 5.38%
CELC Celcuity Inc.	$185M	$24,000 0.0% of portfolio	2,413	Q2 2024 Reduced 29.84%
CDXC Chroma Dex Corp.	$420M	$24,000 0.0% of portfolio	3,548	Q2 2024 New
MGTX Meira G Tx Holdings PLC	$284M	$23,000 0.0% of portfolio	3,446	Q2 2024 Reduced 18.43%
RGNX Regenxbio Inc.	$340M	$23,000 0.0% of portfolio	3,336	Q1 2025 Reduced 91.57%
TBPH Theravance Biopharma, Inc.	$706M	$23,000 0.0% of portfolio	2,661	Q1 2025 Reduced 92.25%
KROS Keros Therapeutics, Inc.	$354M	$22,000 0.0% of portfolio	2,250	Q1 2025 Reduced 92.0%
ALDX Aldeyra Therapeutics, Inc.	$181M	$20,000 0.0% of portfolio	3,610	Q2 2024 Reduced 22.9%
AURA Aura Biosciences, Inc.	$178M	$19,000 0.0% of portfolio	3,361	Q2 2024 Reduced 6.3%
ADGI Adagio Therapeutics, Inc.	$505M	$19,000 0.0% of portfolio	5,747	Q2 2024 New
KMPH Kempharm, Inc	$170M	$19,000 0.0% of portfolio	3,895	Q2 2024 Reduced 21.75%
HRTX Heron Therapeutics, Inc.	$249M	$18,000 0.0% of portfolio	8,507	Q2 2024 Reduced 18.27%
VNDA Vanda Pharmaceuticals Inc.	$253M	$18,000 0.0% of portfolio	4,130	Q2 2024 Reduced 27.29%
TSHA Taysha Gene Therapies, Inc.	$122M	$17,000 0.0% of portfolio	12,635	Q2 2024 Reduced 8.26%
TSVT 2seventy Bio, Inc.	$189M	$17,000 0.0% of portfolio	3,541	Q2 2024 Reduced 29.88%
AVIR Atea Pharmaceuticals, Inc.	$276M	$16,000 0.0% of portfolio	5,591	Q2 2024 Reduced 27.46%
CDXS Codexis, Inc.	$155M	$15,000 0.0% of portfolio	5,931	Q2 2024 Reduced 14.67%
PGEN Precigen, Inc.	$316M	$15,000 0.0% of portfolio	10,576	Q2 2024 Reduced 13.28%
OCGN Ocugen, Inc.	$212M	$15,000 0.0% of portfolio	21,171	Q2 2024 Reduced 12.43%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.